













Class II medical certified device developed in accordance with ICF (International Classification of Functioning, Disability and Health) standards and non-invasive neuromodulation technology. It delivers low-intensity current ranging from 0 to 2mA to targeted brain regions, regulating the resting membrane potential of cerebral cortical neurons to enhance or inhibit neural excitability. Supporting multi-mode stimulation, it is suitable for therapeutic and research applications across neurological rehabilitation, psychiatry, pediatric rehabilitation and other scenarios.
ensuring high patient compliance.
neuromodulation benefits persist from several hours up to 6–12 months, delivering favorable long-term efficacy.
and a wide range of clinical applications.
enabling quick mastery by medical staff.
and therapy rooms with high flexibility, suitable for both clinical and research use.
Post-stroke motor/cognitive/speech disorders, spinal cord injury, post-traumatic brain injury disorders of consciousness
Depression, anxiety disorders, schizophrenia, insomnia, post-traumatic stress disorder (PTSD), dementia
Cerebral palsy, autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), tic disorders, attention deficit
Dysphagia, central pain, neurological dysfunction associated with Parkinson’s disease, adjuvant treatment of epilepsy
Rehabilitation Medicine
Neurology
Psychiatry
Pediatric Rehabilitation Department
ICU/CCU
Sleep Center
Pain Management